Cargando…

The antibody response to SARS-CoV-2 infection persists over at least 8 months in symptomatic patients

BACKGROUND: Persistence of antibodies to SARS-CoV-2 viral infection may depend on several factors and may be related to the severity of disease or to the different symptoms. METHODS: We evaluated the antibody response to SARS-CoV-2 in personnel from 9 healthcare facilities and an international medic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levi, Riccardo, Ubaldi, Leonardo, Pozzi, Chiara, Angelotti, Giovanni, Sandri, Maria Teresa, Azzolini, Elena, Salvatici, Michela, Savevski, Victor, Mantovani, Alberto, Rescigno, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8767777/ https://www.ncbi.nlm.nih.gov/pubmed/35072166 http://dx.doi.org/10.1038/s43856-021-00032-0

Ejemplares similares

SARS-CoV-2 serology in 4000 health care and administrative staff across seven sites in Lombardy, Italy
por: Sandri, Maria Teresa, et al.
Publicado: (2021)

Adverse Events to Comirnaty Vaccine Are Linked to Sex, Age and BMI: Should We Consider Reducing the Dose for Females?
por: Azzolini, Elena, et al.
Publicado: (2023)

Association Between Duration of SARS-CoV-2 Positivity and Long COVID
por: Pozzi, Chiara, et al.
Publicado: (2023)

A ‘Multiomic’ Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019
por: Pozzi, Chiara, et al.
Publicado: (2022)

Antibody Titer Correlates with Omicron Infection in Vaccinated Healthcare Workers
por: Mollura, Maximiliano, et al.
Publicado: (2022)

T cell perturbations persist for at least 6 months following hospitalization for COVID-19
por: Govender, Melissa, et al.
Publicado: (2022)

Analyzing the diffusion and duration of antibodies to SARS-CoV-2 during the natural infection and comparison with vaccination
por: Pozzi, Chiara, et al.
Publicado: (2023)

Persistent COVID-19 symptoms at least one month after diagnosis: A national survey
por: Tleyjeh, Imad M., et al.
Publicado: (2022)

Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months
por: Kim, Su Jin, et al.
Publicado: (2022)

Multicentre Study Into the Use of Polyethylene Glycol With Electrolytes Over at Least 6 Months to Treat Constipation in Paediatric Populations
por: Bautista-Casasnovas, Adolfo, et al.
Publicado: (2023)

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
por: Wagner, Angelika, et al.
Publicado: (2021)

IgG SARS-CoV-2 Antibodies Persist at Least for 10 Months in Patients on Hemodialysis
por: Dudreuilh, Caroline, et al.
Publicado: (2021)

BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
por: Darwich, Abbass, et al.
Publicado: (2022)

Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months
por: Mordant, Francesca L., et al.
Publicado: (2022)

SARS-CoV-2 Natural Antibody Response Persists for at Least 12 Months in a Nationwide Study From the Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2021)

LHC Re-Opening Delayed at Least Two Months
Publicado: (2009)

Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation
por: Lanza, Ezio, et al.
Publicado: (2020)

Gait in patients with symptomatic osteoporotic vertebral compression fractures over 6 months of recovery
por: Jacobs, Eva, et al.
Publicado: (2019)

The effect of COVID-19 epidemic on vital signs in hospitalized patients: a pre-post heat-map study from a large teaching hospital
por: Caruso, Pier Francesco, et al.
Publicado: (2021)

Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals
por: Azzolini, Elena, et al.
Publicado: (2022)

Artificial intelligence processing electronic health records to identify commonalities and comorbidities cluster at Immuno Center Humanitas
por: Morandini, Pierandrea, et al.
Publicado: (2022)

An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study
por: Laino, Maria Elena, et al.
Publicado: (2022)

Social conformity persists at least one day in 6-year-old children
por: Sun, Sai, et al.
Publicado: (2016)

CO130 Dyspnea and Health-Related Quality of Life in Patients with Persistent Symptoms after at Least Six Months of Hospital Discharge Due to COVID-19
por: Lozano, A., et al.
Publicado: (2023)

Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico
por: Romero-Ibarguengoitia, Maria Elena, et al.
Publicado: (2023)

Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity
por: Munker, Dieter, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
por: Rodeles, Luz María, et al.
Publicado: (2021)

Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients
por: Azzolini, Elena, et al.
Publicado: (2022)

Meniscal Root Repair Alone or Combined with Different Procedures After at Least 6 Months of Follow-Up: A Series of Cases
por: Rocha de Faria, José Leonardo, et al.
Publicado: (2022)

Persistent effects of the Yellow River on the Chinese marginal seas began at least ~880 ka ago
por: Yao, Zhengquan, et al.
Publicado: (2017)

Circulating MicroRNAs as Potential Predictors of Anthracycline-Induced Troponin Elevation in Breast Cancer Patients: Diverging Effects of Doxorubicin and Epirubicin
por: Gioffré, Sonia, et al.
Publicado: (2020)

Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma
por: Chen, Viola J., et al.
Publicado: (2019)

A case of microsatellite instability-high clinically advanced castration-resistant prostate cancer showing a remarkable response to pembrolizumab sustained over at least 18 months
por: Shimizu, Kosuke, et al.
Publicado: (2022)

Bleomycin Sclerotherapy for Severe Symptomatic and Persistent Pelvic Lymphocele
por: Fernandes, Ana Sofia, et al.
Publicado: (2014)

Fast Algorithms for Structured Least Squares and Total Least Squares Problems
por: Kalsi, Anoop, et al.
Publicado: (2006)

The Use of Antiviral Agents against SARS-CoV-2: Ineffective or Time and Age Dependent Result? A Retrospective, Observational Study among COVID-19 Older Adults †
por: Desai, Antonio, et al.
Publicado: (2021)

Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients
por: Flehmig, Bertram, et al.
Publicado: (2020)

Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up
por: Dori, Amir, et al.
Publicado: (2021)

Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up
por: Dori, Amir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pha9mg3m4t63btvbe6k71rm9a6